Release Date: 19/10/16 13:14 Summary: Annual Report to shareholders-BRB.AX Price Sensitive: No Download Document 2.09MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%